Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
Vous n'êtes pas connecté
Promising results from nipocalimab drug trial for a rare fetal blood disease suggest a less invasive treatment, offering new hope for affected families.
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
The Johnson & Johnson filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of...
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...
Google's HeAR AI model detects lung diseases like TB and COPD through cough sound analysis, offering a non-invasive, accessible tool for early...
The conditions within a person’s home, family and community affect their ability to stay healthy. Scientists studying these social determinants of...
Merck begins the second phase III study on its LSD1 inhibitor, bomedemstat, for treating certain patients with essential thrombocythemia, a rare blood...
Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today.